Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 3
1999 1
2000 4
2001 1
2002 3
2003 2
2004 1
2005 1
2006 4
2008 2
2009 3
2010 5
2011 11
2012 4
2013 5
2014 3
2015 1
2016 4
2017 3
2018 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels.
Delgado-Ramírez M, Rodriguez-Leal FJ, Rodríguez-Menchaca AA, Moreno-Galindo EG, Sanchez-Chapula JA, Ferrer T. Delgado-Ramírez M, et al. Among authors: sanchez chapula ja. Acta Pharm. 2021 Jun 1;71(2):317-324. doi: 10.2478/acph-2021-0017. Acta Pharm. 2021. PMID: 33151169 Free article.
Inhibition of Kir4.1 potassium channels by quinacrine.
Marmolejo-Murillo LG, Aréchiga-Figueroa IA, Cui M, Moreno-Galindo EG, Navarro-Polanco RA, Sánchez-Chapula JA, Ferrer T, Rodríguez-Menchaca AA. Marmolejo-Murillo LG, et al. Among authors: sanchez chapula ja. Brain Res. 2017 May 15;1663:87-94. doi: 10.1016/j.brainres.2017.03.009. Epub 2017 Mar 11. Brain Res. 2017. PMID: 28288868 Free PMC article.
Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.
Pacheco-Rojas DO, Delgado-Ramírez M, Villatoro-Gómez K, Moreno-Galindo EG, Rodríguez-Menchaca AA, Sánchez-Chapula JA, Ferrer T. Pacheco-Rojas DO, et al. Among authors: sanchez chapula ja. Eur J Pharmacol. 2021 May 15;899:174026. doi: 10.1016/j.ejphar.2021.174026. Epub 2021 Mar 17. Eur J Pharmacol. 2021. PMID: 33722592
Molecular determinants of Kv7.1/KCNE1 channel inhibition by amitriptyline.
Villatoro-Gómez K, Pacheco-Rojas DO, Moreno-Galindo EG, Navarro-Polanco RA, Tristani-Firouzi M, Gazgalis D, Cui M, Sánchez-Chapula JA, Ferrer T. Villatoro-Gómez K, et al. Among authors: sanchez chapula ja. Biochem Pharmacol. 2018 Jun;152:264-271. doi: 10.1016/j.bcp.2018.03.016. Epub 2018 Apr 3. Biochem Pharmacol. 2018. PMID: 29621539
Kir4.1/Kir5.1 channels possess strong intrinsic inward rectification determined by a voltage-dependent K+-flux gating mechanism.
Marmolejo-Murillo LG, Aréchiga-Figueroa IA, Moreno-Galindo EG, Ferrer T, Zamora-Cárdenas R, Navarro-Polanco RA, Sánchez-Chapula JA, Rodríguez-Menchaca AA. Marmolejo-Murillo LG, et al. Among authors: sanchez chapula ja. J Gen Physiol. 2021 May 3;153(5):e201912540. doi: 10.1085/jgp.201912540. J Gen Physiol. 2021. PMID: 33822868 Free PMC article.
Tamoxifen inhibition of kv7.2/kv7.3 channels.
Ferrer T, Aréchiga-Figueroa IA, Shapiro MS, Tristani-Firouzi M, Sanchez-Chapula JA. Ferrer T, et al. Among authors: sanchez chapula ja. PLoS One. 2013 Sep 24;8(9):e76085. doi: 10.1371/journal.pone.0076085. eCollection 2013. PLoS One. 2013. PMID: 24086693 Free PMC article.
High-potency block of Kir4.1 channels by pentamidine: Molecular basis.
Aréchiga-Figueroa IA, Marmolejo-Murillo LG, Cui M, Delgado-Ramírez M, van der Heyden MAG, Sánchez-Chapula JA, Rodríguez-Menchaca AA. Aréchiga-Figueroa IA, et al. Among authors: sanchez chapula ja. Eur J Pharmacol. 2017 Nov 15;815:56-63. doi: 10.1016/j.ejphar.2017.10.009. Epub 2017 Oct 6. Eur J Pharmacol. 2017. PMID: 28993158
62 results